Nib braces for rush of treatments next year
The health insurer’s premium revenue lifted 10.2% to $253 million while its underwriting result was up 11.2% to $25.9 million.
It said that included provision for an expected claims catch-up in healthcare treatment that was deferred during the Covid-19 lockdown but would now happen in the next financial year.
Chief executive Rob Hennin said it was a good result.
“Helping our Kiwi members stay safe and healthy throughout the Covid-19 pandemic has been a priority, which is why we moved quickly to implement an extensive support package,” he said.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.